Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
sarah.fawaz@nds.ox.ac.uk

Sarah Fawaz

Postdoctoral Researcher (ADMIRE)

Key publications

Correction to: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes (Cardiovascular Diabetology, (2024), 23, 1, (50), 10.1186/s12933-024-02133-1)

Gamez M. et al, (2024), Cardiovascular Diabetology, 23

diponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes

Fawaz S. et al, (2024), Diabetes, 73, 964 - 976

Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.

Gamez M. et al, (2024), Cardiovasc Diabetol, 23

Endothelial glycocalyx is damaged in diabetic cardiomyopathy: angiopoietin 1 restores glycocalyx and improves diastolic function in mice

Qiu Y. et al, (2022), Diabetologia, 65, 879 - 894

Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease

Ramnath RD. et al, (2020), Kidney International, 97, 951 - 965

Recent publications

Circulating tumor necrosis factor α in deceased donors promotes kidney injury and associates with inferior short- and long-term graft function and survival.

Fawaz S. et al, (2026), Am J Transplant

Correction to: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes (Cardiovascular Diabetology, (2024), 23, 1, (50), 10.1186/s12933-024-02133-1)

Gamez M. et al, (2024), Cardiovascular Diabetology, 23

diponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes

Fawaz S. et al, (2024), Diabetes, 73, 964 - 976

Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.

Gamez M. et al, (2024), Cardiovasc Diabetol, 23

Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell Fenestrations

Finch NC. et al, (2022), Journal of the American Society of Nephrology, 33, 1120 - 1136

More publications